Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WLYB
WLYB logo

WLYB Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
45.320
Open
43.010
VWAP
44.55
Vol
639.00
Mkt Cap
2.33B
Low
43.010
Amount
28.47K
EV/EBITDA(TTM)
6.64
Total Shares
51.32M
EV
2.94B
EV/OCF(TTM)
11.28
P/S(TTM)
1.44
John Wiley & Sons, Inc., is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany.
Show More

Events Timeline

No data

No data

News

Yahoo Finance
9.5
06-16Yahoo Finance
John Wiley & Sons Reports Strong Cash Flow and AI Growth
  • AI Revenue Growth: John Wiley & Sons saw its AI revenue increase from $40 million to $49 million, demonstrating the company's leadership in the AI economy, with expectations for continued acceleration that will drive a transformation in overall revenue structure.
  • Significant Free Cash Flow Increase: Free cash flow surged by 55% to $195 million, reflecting the company's success in operational efficiency and cost control, which enhances its capital allocation capabilities and potential for shareholder returns.
  • Strategic Importance of Emerald Acquisition: The $450 million acquisition of Emerald Publishing is expected to positively impact earnings per share in the first year, further strengthening the company's market share and content advantage, particularly in finance and economics.
  • Adjusted EBITDA Margin Improvement: The adjusted EBITDA margin improved by 220 basis points to 26.2%, indicating ongoing enhancements in cost management and operational efficiency, which will help boost future profitability and investor confidence.
seekingalpha
9.5
06-16seekingalpha
John Wiley & Sons Q4 Earnings Beat Expectations
  • Earnings Beat: John Wiley & Sons reported a Q4 Non-GAAP EPS of $1.67, exceeding expectations by $0.02, indicating stable profitability amidst market challenges.
  • Revenue Miss: The company generated $447.94 million in revenue for Q4, a 1.2% year-over-year increase, yet fell short of expectations by $2.06 million, highlighting competitive pressures affecting growth.
  • Cash Flow Improvement: Operating cash flow reached $261 million, up 29%, while free cash flow surged to $195 million, a 55% increase, demonstrating significant advancements in cash management and operational efficiency.
  • Positive Outlook: For fiscal 2027, the company projects adjusted EPS between $4.60 and $5.05, with adjusted EBITDA margins expected to rise to 26.5% to 27.5%, reflecting confidence in future growth prospects.
Newsfilter
9.5
06-16Newsfilter
Wiley Reports Strong Fiscal 2026 Results with Record EPS and Cash Flow
  • Revenue and Profit Growth: Wiley reported fiscal 2026 revenue of $1.677 billion, flat year-over-year, but operating income surged to $277 million, a 25% increase, indicating strong performance in the research sector.
  • Adjusted EPS Increase: Adjusted earnings per share (EPS) rose 15% to $4.19, reflecting ongoing investments and growth in research and AI, enhancing shareholder return potential.
  • Sustained Cash Flow Growth: Operating cash flow reached $261 million, up 29% year-over-year, while free cash flow increased by 55% to $195 million, demonstrating significant improvements in capital management and profitability.
  • Strategic Acquisition and Leadership Changes: Wiley acquired Emerald Publishing to bolster its scale and content advantage in research, while appointing a new Chief AI and Data Analytics Officer to further drive commercialization in AI and data analytics.
Newsfilter
2.0
06-15Newsfilter
Wiley and IQVIA Release AI and Science Report
  • Executive Summit Insights: The executive summit co-hosted by Wiley and IQVIA brought together over 25 senior leaders from pharma, academia, and technology to discuss the role of AI in the science-to-patient journey, highlighting the need for cross-sector collaboration.
  • Gap Between AI and Health Systems: The report emphasizes that while AI accelerates every stage from scientific discovery to patient benefit, a significant gap exists between AI's technical capabilities and the health system's ability to absorb these advancements, necessitating structural changes.
  • Five High-Potential Directions: Participants identified five high-potential directions, including decision-first discovery, sharing structured negative data, and deploying patient-facing AI agents, aimed at enhancing the integration of scientific research and clinical application.
  • Challenges of Incentive Structures: The report candidly addresses that existing incentive structures hinder optimization for science, patients, and long-term progress, underscoring the need for collaboration across sectors to achieve necessary structural changes.
Newsfilter
9.5
06-09Newsfilter
Wiley to Release Q4 and FY 2026 Results on June 16, 2026
  • Earnings Release Schedule: Wiley will release its fourth quarter and fiscal year 2026 results before the market opens on June 16, 2026, highlighting the company's ongoing leadership in scientific discovery and innovation.
  • Conference Call Timing: The company has scheduled a conference call at 10 AM ET on the same day to discuss the results, which is expected to attract significant attention from investors and analysts alike.
  • Investor Relations Link: Investors can access real-time information through the company's investor relations page or directly via the specified webcast link, enhancing transparency and communication efficiency.
  • Global Influence: With over 200 years of publishing heritage, Wiley combines trusted academic traditions with AI-powered platforms to transform scientific breakthroughs into real-world impact, further solidifying its central role in the global scholarly ecosystem.
Newsfilter
8.5
06-02Newsfilter
Wiley Acquires Emerald Publishing for £337 Million
  • Transaction Scale and Impact: Wiley has acquired Emerald Publishing for £337 million (approximately $452 million), with a valuation around 7x Adjusted EBITDA, expected to positively impact Adjusted EPS in the first year.
  • Journal Portfolio Expansion: This acquisition expands Wiley's journal portfolio to approximately 2,500 titles, solidifying its leadership in social sciences, particularly in economics, business, and finance, thereby enhancing its competitive edge in the academic publishing market.
  • Revenue and Synergies: Emerald is projected to generate over $85 million in revenue in fiscal year 2026, with 92% recurring subscription revenue, while Wiley anticipates realizing approximately $30 million in annual run-rate cost synergies by year three, further enhancing profitability.
  • Strategic Fit and Future Outlook: The cultural and business compatibility between Wiley and Emerald strengthens Wiley's content advantage in AI and data analytics, enhancing its influence in the global research community and aligning with both companies' long-term growth strategies.
Wall Street analysts forecast WLYB stock price to rise
0 Analyst Rating
Wall Street analysts forecast WLYB stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for John Wiley & Sons Inc (WLYB.N) is 15.67, compared to its 5-year average forward P/E of 12.72. For a more detailed relative valuation and DCF analysis to assess John Wiley & Sons Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
12.72
Current PE
15.67
Overvalued PE
16.11
Undervalued PE
9.33

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.07
Current EV/EBITDA
7.85
Overvalued EV/EBITDA
8.98
Undervalued EV/EBITDA
7.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.26
Current PS
1.32
Overvalued PS
1.44
Undervalued PS
1.08

Financials

AI Analysis
Annual
Quarterly

Whales Holding WLYB

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is John Wiley & Sons Inc (WLYB) stock price today?

The current price of WLYB is 45.32 USD — it has increased 4.85

What is John Wiley & Sons Inc (WLYB)'s business?

John Wiley & Sons, Inc., is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany.

What is the price predicton of WLYB Stock?

Wall Street analysts forecast WLYB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for WLYB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is John Wiley & Sons Inc (WLYB)'s revenue for the last quarter?

John Wiley & Sons Inc revenue for the last quarter amounts to 447.94M USD, increased 1.21

What is John Wiley & Sons Inc (WLYB)'s earnings per share (EPS) for the last quarter?

John Wiley & Sons Inc. EPS for the last quarter amounts to 2.61 USD, increased 110.48

How many employees does John Wiley & Sons Inc (WLYB). have?

John Wiley & Sons Inc (WLYB) has 5200 emplpoyees as of June 18 2026.

What is John Wiley & Sons Inc (WLYB) market cap?

Today WLYB has the market capitalization of 2.33B USD.